Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Change in Acquisitions & Divestments (2019 - 2025)

Equillium (EQ) posted quarterly Change in Acquisitions & Divestments of $4.5 million for Q1 2025, little changed year-over-year from $4.5 million in Q1 2024, and down 25.0% quarter-over-quarter from $6.0 million in Q4 2024.

Analysis

Equillium (EQ) Change in Acquisitions & Divestments (2019 - 2025) Analysis & Trends

Equillium (EQ) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $4.5 million the latest figure, recorded in Q1 2025.

  • In Q1 2025, Change in Acquisitions & Divestments changed 0.0% year-over-year to $4.5 million; the TTM figure through Dec 2025 stood at $4.5 million (down 85.71% YoY), while the FY2025 annual figure was $4.5 million, down 85.71% from the prior year.
  • Change in Acquisitions & Divestments declined to $4.5 million in Q1 2025 per EQ's latest filing, from $6.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $29.0 million in Q2 2021 and bottomed at $2.5 million in Q4 2021.
  • Historically, Change in Acquisitions & Divestments has averaged $10.6 million across 5 years, with a median of $11.0 million in 2023.
  • Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments sank 79.94% — and 2023, when it surged 380.0%.
  • Equillium's Change in Acquisitions & Divestments stood at $2.5 million in 2021, then soared by 179.2% to $7.0 million in 2022, then surged by 71.92% to $12.0 million in 2023, then slumped by 50.0% to $6.0 million in 2024, then retreated by 25.0% to $4.5 million in 2025.
  • Business Quant data shows EQ's Change in Acquisitions & Divestments at $4.5 million in Q1 2025, $6.0 million in Q4 2024, and $12.0 million in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Equillium 249.33 Mn 249.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 4.50 Mn
Dec 31, 2024 6.00 Mn
Sep 30, 2024 12.00 Mn
Jun 30, 2024 9.00 Mn
Mar 31, 2024 4.50 Mn
Dec 31, 2023 12.00 Mn
Sep 30, 2023 11.00 Mn
Jun 30, 2023 15.00 Mn
Mar 31, 2023 12.00 Mn
Dec 31, 2022 6.98 Mn
Sep 30, 2022 15.00 Mn
Jun 30, 2022 8.75 Mn
Mar 31, 2022 2.50 Mn
Dec 31, 2021 2.50 Mn
Sep 30, 2021 16.50 Mn
Jun 30, 2021 28.99 Mn
Mar 31, 2021 12.47 Mn
Dec 31, 2020 8.19 Mn
Sep 30, 2020 5.23 Mn
Jun 30, 2020 8.46 Mn